Fairpointe Capital LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 85 filers reported holding OVID THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 6.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Fairpointe Capital LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$288,000
+2.5%
71,700
-41.1%
0.44%
+736.5%
Q4 2020$281,000
-59.8%
121,7000.0%0.05%
-53.6%
Q3 2020$699,000
-25.2%
121,700
-3.9%
0.11%
-17.6%
Q2 2020$934,000
+121.3%
126,700
-10.6%
0.14%
+115.9%
Q1 2020$422,000
-28.2%
141,7000.0%0.06%
+40.0%
Q4 2019$588,000
+79.8%
141,700
+40.3%
0.04%
+164.7%
Q3 2019$327,000
+74.9%
101,0000.0%0.02%
+112.5%
Q2 2019$187,000
+4.5%
101,0000.0%0.01%
+33.3%
Q1 2019$179,000
+80.8%
101,000
+146.3%
0.01%
+100.0%
Q4 2018$99,00041,0000.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$4,32918.57%
Madison Avenue Partners, LP 3,307,605$10,848,9432.37%
CHI Advisors LLC 864,822$2,836,6160.86%
Rubric Capital Management LP 5,445,910$17,862,5850.76%
BVF INC/IL 6,851,051$22,471,4470.63%
EcoR1 Capital, LLC 6,117,400$20,065,0720.49%
Artal Group S.A. 2,500,000$8,2000.25%
Tejara Capital Ltd 112,591$369,2980.18%
DCF Advisers, LLC 64,764$212,4260.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 801,152$2,627,7790.06%
View complete list of OVID THERAPEUTICS INC shareholders